Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients

xloma.fota13 shared this article with you from Inoreader Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients Via Journal of Infectious Diseases - Advance Access Abstract Routine monitoring of Parvovirus B19 (B19V) the first six months post-transplantation was performed in 241 seronegative solid organ transplant (SOT) recipients. Incidence rates (IR) during the 1st month and the 2nd to 6th months post-transplantation were 1.2 (95% CI, 0.33-3.2) and 0.21 (95% CI, 0.06-0.57) per 100 recipients per-month, respectively. Of the 6 SOT recipients with positive B19V PCR, 3 (50%) were admitted to hospital and 2 (33%) were treated with intravenous immunoglobulin. Thus, routine monitoring of B19V in seronegative SOT recipients may not be necessary. Targeted screening one-month post-transplantation and screening upon clinical suspicion could be an alternative strategy. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.